Combining Epigenetic and Cytotoxic Therapy in the Treatment of Solid Tumors-Reference-Cited by-同舟云学术

Combining Epigenetic and Cytotoxic Therapy in the Treatment of Solid Tumors

Published:2007-10-10 Issue:29 Volume:25 Page:4519-4521
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Plimack Elizabeth R.¹,Stewart David J.¹,Issa Jean-Pierre J.¹

Affiliation:

1. The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.12.6029

Reference29 articles.

1. Gene Silencing in Cancer in Association with Promoter Hypermethylation

2. Lenalidomide and Thalidomide: Mechanisms of Action—Similarities and Differences

3. Plumb JA, Strathdee G, Sludden J, et al: Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res 60:6039,2000-6044,

4. Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms

5. DNA Methylation as a Therapeutic Target in Cancer: Fig. 1.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement;Molecular Diversity;2024-03-30

2. Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine;Leukemia & Lymphoma;2022-11-12

3. Carbohydrate-based drugs launched during 2000−2021;Acta Pharmaceutica Sinica B;2022-10

4. Targeting Epigenetic Modifications in Uveal Melanoma;International Journal of Molecular Sciences;2020-07-27

5. ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype;Oncogene;2020-06-07